Syntheses and single-crystal X-ray structural characterizations (at c. 295 K) are recorded for the 1 : 1 adducts of copper(I) chloride, bromide and iodide with L = 2,2′-bipyridine. The chloride is triclinic, Pī , a 14.069(5), b 10.520(3), c 7.872(2)Ǻ, α 69.00(2), β 88.62(3), γ 70.70(2)°, Z = 4 formula units; R was 0.041 for No 1805 'observed' [I > 3σ(I)] reflections. The bromide is monoclinic, P21/c, a 8.788(3), b 13.206(6), c 9.895(3)Ǻ, β 117.90(2)°, Z = 4 formula units; R 0.036 for No 1007. The iodide is monoclinic, C2/c, a 17.571(3), b 8.587(7), c 16.796(3)Ǻ, β 120.17(2)°, Z = 8 formula units; R 0.041 for No 1038. The chloride is ionic, [CuL2]+ [ ClCuCl ]-; in the cation, Cu-N are 2.005(6)-2.039(6)Ǻ with interligand N-Cu-N 114.4(3)-132.4(2)°, while, in the anion, Cl-Cu-Cl is 177.3(1)°, with Cu-Cl 2.086(2) and 2.091(2)Ǻ. The bromide (unlike its 1,10-phenanthroline counterpart, which is ionic) is a centrosymmetric dimer , as also is the iodide. In the bromide, Cu-N are 2.083(6), 2.099(5), and Cu-Br 2.428(2), 2.463(1)Ǻ, Cu…Cu and Br…Br being 2.850(1) and 3.975(2)Ǻ respectively. In the iodide, Cu-N are 2.070(8), 2.08(1), and Cu-I, 2.583(3)Ǻ (×2), and Cu…Cu and I…I are 2.610(2) and 4.420(1)Ǻ.
Syntheses and room-temperature single-crystal X-ray structural characterizations are recorded for a number of adducts of Group 2 halides with the aromatic N,N′- bidentate ligands L = 2,2'-bipyridine ( bpy ) and 1,10-phenanthroline ( phen ). One adduct of 1 : 1 MX2/L stoichiometry is recorded: [( bpy )Ca(μ-Br)(4/2)](∞ ׀ ∞) (1) is monoclinic, C 2/c, a l7.102(5), b 9.845(1), c 7.600(2) Ǻ, β 107.65(2)°, Z = 4 f.u .; conventional R on #1472; F ׀ at convergence was 0.057 for No 817 independent 'observed' ( I > 3σ(I)) reflections, the compound being a one-dimensional polymer… CaL (μ-Br)2CaL(μ-Br)2…, with six-coordinate calcium, cis-CaN2(μ-Br)4, on a twofold axis. 1 : 2 MX2/L systems have been described for two types of array: [( bpy )2CaI2] (2), orthorhombic, Pnca, a 16.914(4), b 13.80(1), c 9.290(4) Ǻ, Z = 4 f.u .; R 0.039 for No 1738, is discrete mononuclear, containing cis-CaN4I2 six-coordinate calcium, whereas the barium analogue is an infinite one-dimensional polymer, [( bpy )2Ba(μ-I)(4/2)](∞׀ ∞) (3), triclinic, Pī, a 11.318(2), b 11.078(2), c 9.206(4) Ǻ, α 80.87(2), β 77.52(2), γ 87.53(1)°, Z = 2 f.u .; R 0.032 for No 4154, with eight-coordinate (N2)2Ba(μ-I)4. The perchlorate analogue, [( bpy )2Ba(μ-OClO2O)(4/2)](∞ ׀ ∞) (4), although of similar stoichiometry, has a trans-rather than a cis-linked chain; it is monoclinic, P 21/c, a 6.606(2), b 18.661(7), c 19.440(8) Ǻ, β 109.45(4)°, Z = 4 f.u .; R 0.044 for No 4060, with μ-I replaced by O,O'-ClO4 bridging units and eight-coordinate barium, (N2)2BaO4. The 1 : 3 MX2/L system is represented (as its hemi( bipyridine ) 'solvate') by mononuclear [( bpy )3SrI2].0.5bpy (5), monoclinic, P 21/c, a 20.834(8), b 9.735(4), c 18.460(7) Ǻ, β 114.87(3)°, Z = 4 f.u .; R 0.039 for No 3711, containing eight-coordinate strontium, [(N2)3SrI2]; there is also an isomorphous calcium/ perchlorate analogue [( bpy )3Ca(OClO3)2].0.5bpy (6), a 21.413(6), b 9.813(4), c 18.659(2) Ǻ, β 115.67(2)°, R 0.057 for No 3090, in which unidentate O-ClO4 ligands replace the iodine about the metal atom. A 1 : 4 adduct is obtained with CaI2/phen; ionic [Ca( phen )4] I2 (7), triclinic, Pī , a 14.703(3), b 13.292(3), c 11.38(1) Ǻ, α 92.78(4), β 96.15(4), γ 105.22(2)°, Z = 2 f.u ., R 0.053 for No 3658, contains eight-coordinate Ca(N2)4 arrays, while the novel 1 : 5 adduct [ Ba ( phen )4] I2.MeCN (8) is triclinic, Pī , a 12.170(6), b 13.760(7), c 18 254(8) Ǻ, α 77.05(9), ,β 71.96(4), γ 70.83(9)°, Z = 2 f.u ., R 0.040 for No 4447, containing 10-coordinate barium, [ Ba (N2)5]. A 1 : 4 adduct formed with BaBr2 is [ BrBa( phen )4] Br.MeOH (9), triclinic, Pī , a 17.748(4), b 17.418(2), c 15.535(7) Ǻ, α 91.63(2), β 100.53(3), γ 115.39(1)°, Z = 4 f.u ., R 0.062 for No 4092, containing nine-coordinate barium, [ BrBa (N2)4].
Adducts (1 : 1) of copper(I) chloride, bromide and thiocyanate with quinoline have been synthesized and have been the subject of single-crystal X-ray structure determinations at 295 K. Crystals of the chloride are orthorhombic, P 212121, a 15.358(7), b 14.309(6), c 3.801(2)Ǻ, Z 4; R was 0.055 for 541 'observed' reflections. Crystals of the bromide are monoclinic, C2/c, a 19.417(5), b 14.048(4), c 15.753(6) Ǻ, β 125.31(2)°, Z 4 tetramers; R was 0.049 for 1138 'observed' reflections. Crystals of the thiocyanate are monoclinic, P 21/c, a 5.682(1), b 10.412(2), c 16.838(5)Ǻ, β 97.48(2)°, Z 4 f.u .; R was 0.045 for 914 'observed' reflections. The chloride takes the form of the common 'stair' polymer, unexpectedly, while the thiocyanate is an expanded version of the same. The bromide provides a second example of a novel tetrameric 'basket' structure exemplified previously by the iodide analogue.
Room-temperature single-crystal X-ray structural characterizations are recorded for a variety of adducts of Group 2 metal halides with 2,2':6',2?-terpyridine ( tpy ) from various hydroxylic solvents. [Mg( tpy )2][Mg( tpy )(OH2)3] Br4.PriOH (1) is triclinic, Pī, a 19.352(6), b 12.852(5), c 11.463(3) Ǻ, α 110.95(3), β 99.04(2), γ 98.81(3)°, Z = 2 f.u .; conventional R on ׀ F ׀ at convergence was 0.056 for No 4398 independent 'observed' (I > 3σ(I)) reflections. In the [Mg( tpy )2]2+ ion, Mg-N(central; distal) are 2.099(9), 2.09(1); 2.152(9)-2.212(8) Ǻ, while in [Mg( tpy )(OH2)3]2+, Mg-N(central; distal) are 2.139(7); 2.206(9), 2.222(9) Ǻ, while Mg-O trans to these are 2.042(6); 2.082(9), 2.097(8) Ǻ. [Mg( tpy )(OH2)2( MeOH )] Cl2 (2) is triclinic, Pī, a 14.049(7), b 8.354(4), c 8.301(2) Ǻ, α 74.25(3), β 73.05(3), γ 80.37(4)°, Z = 2 f.u., R 0.064 for No 2417. In the cation, Mg-N(central; distal) are 2.125(4); 2.203(4), 2.218(4) Ǻ; Mg-O( MeOH ) is trans to Mg-N(central), being 2.013(4) Ǻ; Mg-O(OH2) are 2.067(4) and 2.063(4) Ǻ. [CaCl2( tpy )( dmf )2 (3) ( dmf = N,N- dimethylformamide ) is monoclinic, C2/c, a 23.27(2), b 11.225(6), c 16.517(8) Ǻ, β 109.56(5)°, Z = 4 centrosymmetric dimers, R 0.061 for No 985. The calcium atoms are linked by a pair of μ-chlorines, CaCl2Ca, and are seven-coordinate, N3Ca(μ-Cl )4 being broadly coplanar in the equatorial plane of a pentagonal bipyramidal array, with the other chlorine and the dmf oxygen trans and axial.
Recrystallization of anhydrous Group 2 halides from anhydrous acetonitrile has yielded, in a number of cases, adducts MX2.nMeCN suitable for characterization by room-temperature single-crystal X-ray studies, which revealed novel stereochemical types. Magnesium(II) bromide yields a trisolvate, ionic with disproportionated ligand arrays, as [Mg(NCMe)6][MgBr4] (1), an unusual combination of homoleptic cationic and anionic species. Crystals are triclinic, Pī , a 19.129(1), b l6.870(8), c 8.737(7) Ǻ,α 83.96(3), β 87.93(4), γ 65.24(2)�, Z=4 f.u .; R was 0.068 for N o 3181 'observed' (I > 3σ(I)) reflections. Mg-N are 2.12(2)-2.18(2) Ǻ, and Mg-Br are 2.452(7)-2.481(6) Ǻ. Calcium(II) bromide, by contrast, yields a disolvate , an infinite polymer, with the two MeCN ligands trans in a quasi-octahedral coordination sphere, and the polymer comprising a ... Ca(μ-Br)2Ca(μ-Br)2... linear array. Crystals of 1:2 CaBr2/MeCN (2) are orthorhombic, Pbam , a l4.252(3), b 8.539(2), c 4.2088(6) Ǻ, Z=2 f.u .; R 0.043 for N o 352. Ca-N is 2.46(1) Ǻ, and Ca-Br 2.8765(9) Ǻ. CaI2 and SrI2 yield pentasolvates as neutral, molecular species [( MeCN )5MX2] (3) and (4), with the halides trans in a pentagonal bipyramidal coordination sphere. They are isomorphous . orthorhombic, Pcab , a ≈ 18.4, b ≈ 14.6, c ≈ 14.3 Ǻ, Z = 8 f.u .; R were 0.042 and 0.059 for N o 2297 and 1489 respectively. Ca-I are 3.132(2), 3.116(2) Ǻ and Sr -I are 3.265(3), 3.238(3) Ǻ, while Ca-N are (range) 2.518(8)-2.566(8) Ǻ and Sr -N 2.68(2)-2.73(2) Ǻ.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.